Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 4,414,873 |
|
|||||
| News | - | ||||||
| Day High | 1.65 | Low High |
|||||
| Day Low | 1.56 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Perspective Therapeutics Inc | CATX | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.14 | -8.28% | 1.55 | 19:56:26 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.65 | 1.56 | 1.65 | 1.60 | 1.69 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 13,772 | 4,414,873 | $ 1.61 | $ 7,092,437 | - | 0.205 - 1.77 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 20:00:00 | 84,399 | $ 1.60 | USD |
Perspective Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 448.91M | 280.57M | - | 1.43M | -46.51M | -0.17 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Perspective Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CATX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.45 | 1.77 | 1.33 | 1.60 | 5,224,261 | 0.10 | 6.90% |
| 1 Month | 1.25 | 1.77 | 1.15 | 1.47 | 6,415,607 | 0.30 | 24.00% |
| 3 Months | 0.80 | 1.77 | 0.7178 | 1.26 | 4,062,048 | 0.75 | 93.75% |
| 6 Months | 0.27 | 1.77 | 0.2201 | 1.07 | 2,517,180 | 1.28 | 474.07% |
| 1 Year | 0.6615 | 1.77 | 0.205 | 0.9295249 | 1,589,253 | 0.8885 | 134.32% |
| 3 Years | 0.3763 | 1.77 | 0.205 | 0.9042086 | 1,457,333 | 1.17 | 311.91% |
| 5 Years | 0.3763 | 1.77 | 0.205 | 0.9042086 | 1,457,333 | 1.17 | 311.91% |
Perspective Therapeutics Description
| Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company. The Company is engaged in the advancement of treatment applications for cancers throughout the body. It is a producer of Cesium-131 brachytherapy seeds. These seeds are designed to treat a variety of cancers including prostate cancer, head and neck, lung and brain. The Company has also developed a lead-212 generator to secure isotope supply for clinical trials and commercial operations. Its lead-212 generator utilizes the isotope lead-212 to deliver alpha radiation specifically to cancer cells via specialized targeting peptides. The Company is also engaged in the development of imaging diagnostics (Pb-203 (Lead-203)). The Company¿s melanoma (VMT01) and neuroendocrine tumor (VMT-a-NET) programs are under Phase I/IIa imaging and therapy trials for the treatment of metastatic melanoma and neuroendocrine tumors at various academic institutions. |
